Cancer Cachexia Market Size is Projected to Reach US$ 2.53 Billion 2022-2027
According to the latest report by IMARC Group, titled " Global Cancer Cachexia Market Size, Share, Industry Trends, Growth, Opportunity and Forecast 2022-2027 ", the global cancer cachexia market reached a value of US$ 1.88 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 2.53 Billion by 2027, exhibiting a CAGR of 4.80% during 2022-2027. Cancer cachexia refers to a multifactorial wasting syndrome characterized by weight loss, anemia, systematic inflammation, anorexia, asthenia, involuntary loss of lean body mass and appetite, and negative protein and energy balance. It is caused due to various chronic conditions, such as tuberculosis, chronic renal failure, multiple sclerosis, human immunodeficiency virus (HIV), and chronic obstructive pulmonary disease (COPD). Cancer cachexia can be treated using several therapeutics, including progestogen, corticosteroid, and combination therapy, to alleviate the symptoms, enhance the response to c...